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Abstract
The aim of this study was to assess health-related quality of life (HRQL) in patients with chronic
obstructive pulmonary disease (COPD) and to discuss the different tools available for its assessment.
The most widely used assessments are the St. George respiratory questionnaire (SGRQ) and the COPD
assessment test (CAT) questionnaire. Both have a different difficulty in exam completion, calculation, and
scoring. No studies exist that analyze the validity and internal consistency of using both questionnaires on
patients admitted to the hospital for a COPD exacerbation. A multicenter, cross-sectional analytic
observational study of patients admitted to the hospital due to a COPD exacerbation (CIE 491.2).
During their hospital stay, they were administered the SGRQ and the CAT questionnaire within the
framework of a therapeutic education program (APRENDEPOC). Descriptive and comparative analysis,
correlations between the scales (Pearson’s correlation index), consistency and reliability calculations
(Cronbach’s a), and a forward stepwise multiple linear regression were performed, with significant
correlations in both questionnaires considered p < 0.01 with the total scores. A statistical significance
of p < 0.05 was assumed. Altogether, 231 patients were admitted for a COPD exacerbation (n ¼ 77) at
Hospital Clı´nic of Barcelona (HCB) and (n ¼ 154) at Hospital Universitario General of Castello´n
(HUGC). The sample profile was not homogeneous between both centers, with significant differences
in HRQL between hospitals. Correlation were noted between both scales (p < 0.01), along with high
levels of internal consistency and reliability (CAT 0.836 vs. SGRQ 0.827). The HRQL is related to
dyspnea, wheezing, daytime drowsiness, and edema, as well as to the need to sleep in a sitting
position, anxiety, depression, and dependence on others in the execution of daily activities. Our
regression analysis showed that the SGRQ questionnaire could predict more changes in HRQL with a
higher number of variables.
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Introduction
Chronic obstructive pulmonary disease (COPD) is
one of the main causes of morbidity and mortality
throughout the world.1 Eighty million individuals
endure a moderate or serious stage of the disease.2
Initiatives to standardize COPD treatment, such as the
Spanish COPD (GESEPOC) guide3 or the Initiative
for Chronic Global Obstructive Lung Disease
(GOLD),4 have increased the homogeneity of COPD
diagnosis and treatment, although COPD continues to
be a disease with high health costs, which among
other reasons is because of the high number of read-
missions due to exacerbation.5 Therefore, there is a
need to manage these patients in an integral manner,
seeking to alleviate their symptoms, improve their
exercise tolerance, increase their health status, and
improve their overall quality of life.6,7
With quality of life being a predictive factor of
exacerbation in patients with COPD, it is important
to conduct a routine assessment using valid and reli-
able scales on the impact of COPD on the patient’s
health status.8 This makes health-related quality of
life (HRQL) one of the most studied items in clinical
trials on the patients with COPD.9 Despite the interest
generated by studying HRQL, there is a consensus
only on the use of the COPD assessment test (CAT)
questionnaire in stable patients with COPD as a
method to predict the risk of a future exacerbation,
as indicated in the GOLD guide4 and the Spanish
COPD (GESEPOC) guide.3 There is no consensus
on the most indicated questionnaire to evaluate the
patients with COPD during an exacerbation, although
several extended questionnaires exist for this purpose
and have been adapted to different languages10 and
populations. Their reliability, worth, precision, con-
sistency, and sensitivity to change have been demon-
strated but important differences exist in their content,
ease of calculation, and completion.9
One of these questionnaires is the CAT,8 which
consists of eight questions. Each item is scored from
0 to 5 giving a total score range from 0 to 40. It has
good internal consistency, and a completion time of
107 seconds, as validated through an international
sample of 1000 patients.11 Its administration may be
through an interview, or self-completed.12
Another frequently used questionnaire is the
St. George respiratory questionnaire (SGRQ),
designed by Jones in 1991,13 to measure the subjec-
tive perception of HRQL. It is the most commonly
used questionnaire and considered the gold standard
in the assessment of HRQL. It has been validated in
several languages for use via telephone.10,14 It con-
tains 76 questions that are organized into three cate-
gories: symptoms, activity, and impact. Each question
has an empirically derived weight, making it neces-
sary to calculate the score through a computer appli-
cation. The SGRQ is therefore more complicated to
calculate and is lengthy, with a completion time of
578 seconds.15 It is difficult to fill out without aid
from the health staff, as reported by other authors.16
Further, controversy exists on the cutoff point of its
scale.17 Given the applicability problems of the
SGRQ scale, the SGRQ-c questionnaire was recently
created with 40 questions, but its lack of validity in
different languages has limited its use, and the SGRQ
questionnaire is still the most used.
As the SGRQ is somewhat inadequate in routine
clinical practice, it is necessary to use short question-
naires that gather appropriate information and improve
the communication between patients and health staff.18
An example is the CAT questionnaire.19
For all of the above, the CAT questionnaire can
replace the SGRQ questionnaire, as there are studies
that have evaluated the metric parameters of both ques-
tionnaires and noted a significant correlation between
both scales in the stable COPD population15,20–22 and
displays good sensitivity levels to change and internal
consistency in patients with stable and exacerbated
COPD in the primary care setting.8,11,23,24 This corre-
lation between both scales has also been studied in
patients with interstitial lung disease.25 No studies have
assessed their correlation and similarity in a population
with exacerbated COPD in the hospital setting during a
hospital admission for the exacerbation of their respira-
tory pathology.
Our general objective was to evaluate and compare
the psychometric properties of the SGRQ and CAT
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questionnaires in patients with COPD admitted for an
exacerbation (CIE 491.2) to two national hospitals.
Secondary objectives:
 Gain knowledge of and compare the character-
istics of the population using all of the studied
variables (sociodemographic, clinical, psycho-
logical and activity index, and HRQL).
 Understand the homogeneity and reliability of
the total results of both the SGRQ and CAT
questionnaires, as well as between the subgroups
of the SGRQ questionnaire (symptoms, activity,
and impact) and questions from the CAT.
 Know what population characteristics have a
greater association with the total scores
obtained in the SGRQ and CAT and determine
which questionnaire can best explain a greater
variance.
Methodology
Design
A cross-sectional, observational study of patients
admitted to two hospitals with diagnosis of a COPD
exacerbation with CIE code 491.2 and who were
administered the SGRQ and CAT questionnaires
within the first 3 days of hospitalization. Completion
of the questionnaires was conducted during the initial
assessment of an experimental study with two assign-
ment groups, with analysis before and after the inter-
vention. The subjects were randomly assigned to an
experimental group or a comparison group. The inter-
vention consisted of four education and telephone
follow-up sessions, with evaluation after 3 months.26
Population and setting
The Hospital Clı´nic of Barcelona (HCB; Barcelona-
Izquierda, 323,000 inhabitants) and Hospital Universi-
tario General of Castello´n (HUGC; Area 2, Department
of Health of Castello´n, 268,231 inhabitants).
Selection criteria: Patients diagnosed with COPD,
based on a history of smoking (active or previous) of
at least 20 packs per year, along with the presence of
a scarcely reversible airflow obstruction, are defined
as a forced expiratory volume ratio on the first sec-
ond (FEV1)/forced vital capacity (FVC) below 70
after bronchodilation. Patients presented to our
emergency service and required admission to the
hospital for dyspnea produced by COPD exacerba-
tion with the CIE 491.2 diagnosis code. They parti-
cipated in the study voluntarily after receiving an
explanations and understanding the purpose and
interventions of the study.
Exclusion criteria: All patients who could not com-
municate due to physical or mental disabilities were
in an advanced state with a life expectancy of less
than 6 months or who fulfilled the inclusion criteria
but refused to participate in the study.
The recruitment period was 2 years and 3 months
(February 2014 to May 2016) by means of consecutive
sampling, with estimated a sample size, per center,
based on the annual average of patients who fulfilled
the inclusion criteria. This produced a sample size of
n ¼ 50 from HCB and n ¼ 150 for HUGC, with an
expected loss of 22% based on prior literature.27
Variables
Main variables. The HRQL measured through:
 The SGRQ28 adapted into Spanish and con-
sisted of 50 items (covering 76 levels) divided
into three subscales: symptoms (8 questions),
activity (16 questions), and impact (26 ques-
tions). All the questions were measured as per-
centages and means, and each question has an
attributed weight. The total score was obtained
from the sum of the three categories, ranging
from 0 to 100, with the highest scores indicat-
ing a worse quality of life. The full scale has a
Cronbach’s a of 0.94, with subscale scores of
0.72 for symptoms, 0.89 for activity, and 0.89
for impact.
 The CAT questionnaire8 consisted of eight
questions (cough, phlegm, chest tightness,
breathing difficulty during daily life activities,
limitation in household activities, confidence to
leave the house, sleep, and energy). The range
of scores for each element is between 0 and 5,
and the total result is the sum of the eight ques-
tions. Its Cronbach’s a was 0.88.11,23
Sociodemographic variables
Gender, age, and educational level.
Clinical variables
The degree of dyspnea was measured with the Med-
ical Research Council (MRC) scale,29 which has five
classification options that range from 0 to 4—ranging
from a low to high degree of difficulty in the execu-
tion of physical activities. The presence of absence of
Folch Ayora et al. 3
coughing, expectoration, fever, the need to sleep in a
sitting position, and edema was evaluated. Pain was
assessed with a numeric rating scale (NRS) that range
from 0 to 10, from least to greatest pain. Variables
were obtained through interviews with patients.
Co-morbidities were based on a review of the
patient’s clinical history (no. of comorbidities), and
the Charlson index modified by age, which classifies
the degree of comorbidity into three categories
(absence 0–1; low 2; high 3),30 was calculated.
Psychological variables
Anxiety and depression were assessed with the
Hospital Anxiety and Depression scale31,32 which
consists of 14 questions (seven aspects of anxiety,
seven of depression) with four possible answers, with
values that ranged from 0 to 3. The final result is
separate sum of questions about anxiety and depres-
sion. Results were interpreted in the following
manner: 0–7, no case; 8–10, a doubtful case; and
>11, a probable case.
Activity variables
The variables were evaluated using the Barthel ques-
tionnaire on the patient’s dependence on others in the
performance of activities of daily living. The metric is
composed of 10 Likert-type items. The score cate-
gories are as follows: 0–20, total dependence;
21–60, severe dependence; 61–90, moderate
dependence; 91–99, scarce dependence; and 100,
independence.33
Statistical analysis
Descriptive analysis of population characteristics was
presented as percentages and means () + typical
standard deviation (SD). Comparative analysis of
patients’ characteristics was by centers. For nonpara-
metric data, Fisher’s exact test was used for qualita-
tive data and the Mann–Whitney U-test was used for
quantitative data. For parametric data, the chi-squared
test was used for qualitative data and Student’s t-test
was used for quantitative data.
Relationship between the three dimensions of the
SGRQ (symptoms, activity, and impact) and the eight
questions from the CAT questionnaire and Pearson’s
correlation (R) index was used. To calculate the relia-
bility and internal consistency of these metrics, Cron-
bach’s index and Cronbach’s a coefficients at a 95%
confidence interval were calculated.
To identify the variables that influence the total
scores of the CAT and the SGRQ questionnaires, a
univariate analysis was performed with Pearson’s R
index. The variables that were statistically significant
(p < 0.05) in both questionnaires were selected as
independent variables for a forward stepwise multiple
linear regression analysis. The first variable intro-
duced in the model was the variable that had the
greatest correlation with the total score of the SGRQ
and CAT questionnaires, with the rest of the variables
that correlated with the total scores of the question-
naires successively added.
For purposes of interpretation, all p values were
reported, and p < 0.05 was considered statistically
significant. Our statistical study used the SPSS soft-
ware v.23 for Windows.
Ethical considerations
This study was approved by the bioethics and
research committee at HCB, HUGC, and the Deon-
tological Commission at Universitat Jaume I. Its
design and implementation were carried out follow-
ing the rules specified to the Helsinki Declaration.
Data treatment was based on the Organic Law on the
Protection of Personal Data, 15/1999 of 13 Decem-
ber. Participant anonymity and data confidentiality
were guaranteed. Data were not accessible to indi-
viduals outside of the study.
Results
Population characteristics
A total of 231 patients were admitted for a COPD
exacerbation, 77 to HCB, and 154 to HUGC. The
population profile was 81.4% (n ¼ 188) male, with
a mean age of 73.3 + 9.3 years and basic studies
performed in 47.6% (n ¼ 110) of the cases.
Clinically, 37.6% (n ¼ 85) had grade III dyspnea
according to the MRC scale, 66.8% (n ¼ 157) had a
cough, 75.3% (n ¼ 177) had expectoration, 40.9%
(n ¼ 96) had wheezing, and high comorbidity burden
was present in 89.6% (n ¼ 207). Anxiety was present
in 18.3% (n ¼ 42) of patients, and depression was
diagnosed in 20.9% (n ¼ 48). The need for help to
carry out basic daily life activities was moderate in
40.3% (n ¼ 93) of the cases.
The patient profile was homogeneous in variables
such as age (p ¼ 0.189), gender (p ¼ 0.141), and
expectoration (p ¼ 0.410). The remaining variables
studied were different between the hospitals
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Table 1. Characteristics of the total sample and by hospital.
Sociodemographic Total (N ¼ 231) HCB (n ¼ 77) HUGC (n ¼ 154) p
Gender n (%)b
Males 188 (81.4) 66 (85.7) 122 (79.2) 0.189
Females 43 (18.6) 11 (14.3) 32 (20.8)
Age mean+ (SD)c 73.3+ 9.3 72.4 + 7.9 73.7 + (9.8) 0.141
Level of studiesb
Without studies 33 (14.3%) 7 (9.1%) 26 (16.9%) 0.062
Basic studies 110 (47.6%) 35 (45.5%) 75 (48.7%)
Secondary studies or FP 65 (28.1%) 23 (29.9%) 42 (27.3%)
University studies 23 (10.0%) 12 (15.6%) 11 (7.1%)
Clinical variables
Dyspnea (MRC) n (%)c
0 5 (2.2%) 2 (2.6%) 3 (2.0%) <0.001
I 24 (10.6%) 18 (23.4%) 6 (4.0%)
II 69 (30.5%) 39 (50.6%) 30 (20.1%)
III 85 (37.6%) 18 (23.4%) 67 (45.0%)
IV 43 (19.0%) – 43 (28.9%)
Cough n (%)a 157 (66.8%) 64 (83.1%) 93 (60.4%) 0.001
Expectoration n (%)a 177 (75.3%) 62 (80.5%) 115 (74.7%) 0.410
Wheezing n (%)a 96 (40.9%) 22 (28.6%) 74 (48.1%) 0.005
Daytime drowsinessa 53 (22.6%) 6 (7.8%) 47 (30.5%) 0.000
Fever n (%)a 27 (11.5%) 3 (3.9%) 24 (15.6%) 0.009
Edema n (%)a 63 (26.8%) 6 (7.8%) 57 (37.0%) <0.001
Need to sleep in sitting positiona 93 (39.6%) 4 (5.2%) 89 (57.8%) <0.001
Pain (VAS) mean+ (SD)d 0.97+ 1.9 0.09 + 0.4 1.4 + (2.3) <0.001
No. of comorbidities mean+ (SD)c 3.1 + 2.1 3.6 + 2.3 2.9 + 2.0 0.010
Charlson index n (%)a
Absence 7 (3.0%) 4 (5.2%) 3 (2.0%) 0.008
Low 13 (5.6%) 9 (11.7%) 4 (2.7%)
High 207 (89.6%) 64 (83.1%) 143 (95.3%)
Psychological variables
Anxiety n (%)a
No case 136 (59.1%) 51 (66.2%) 85 (55.5%) 0.037
Doubtful case 52 (22.6%) 13 (16.9%) 39 (25.5%)
Probable case 42 (18.3%) 13 (16.9%) 29 (19.0%)
Depression n (%)a
No case 129 (56.1%) 50 (64.9%) 79 (51.6%) 0.003
Doubtful case 53 (23.0%) 16 (20.8%) 37 (24.2%)
Probable case 48 (20.9%) 11 (14.3%) 37 (24.2%)
Basic daily life activitiesd
Barthel’s index n (%)a
Total dependence 8 (3.4%) – 8 (5.2%) <0.001
Severe dependence 33 (14.3%) 1 (1.3%) 32 (20.8%)
Moderate dependence 93 (40.3%) 17 (22.1%) 76 (49.4%)
Scarce dependence 12 (5.2%) 3 (3.9%) 9 (5.8%)
Independence 85 (36.8%) 56 (72.7%) 29 (18.8%)
HRQL
CAT_total mean+ (SD) 41.9+ 8.6 18.6 + 7.6 23.6 + 7.6 <0.001
SGRQ_total mean+ (SD) 50.2+ 19.6 51.2 + 17.8 49.6 + 20.5 <0.001
HCB: Hospital Clı´nic of Barcelona; HUGC; Hospital Universitario General of Castello´n; p: p-value; MRC: Medical Research Council;
VAS: visual analogue scale; HRQL: health-related quality of life.
aFisher’s exact test.
bPearson’s chi-squared test.
cStudent’s t-test.
dMann–Whitney U-test.
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(p < 0.05), with the most significant (p < 0.001)
differences being dyspnea, daytime drowsiness,
edema, pain, the number of comorbidities, and
dependence in the performance of daily activities
(Table 1).
The homogeneity and reliability of the total results
of both questionnaires
Patients presented with greatly affected HRQL, inde-
pendent of the scale used, despite the significant
Table 2. Internal consistency and correlation between scales.
Possible range
of scores Questions Correlation
Cronbach’s a
coefficient (95% CI) Mean+ SD Ma-xMin
CAT_total (0–40) 8 0.614a 0.827 (0.791–0.859) 21.9 + 8.0 65–2
SGRQ_total (0–100) 50 0.836 (0.795–0.869) 50.2 + 19.6 96–8
CAT: COPD assessment test; SGRQ; St. George Questionnaire; CI: confidence interval; SD: standard deviation; Max: maximum; Min:
minimum.
aThe correlation is significant on level 0.01(bilateral).
Table 3. Correlation matrix of the health-related quality-of-life questionnaires.
SRGQ_SYMPTOMS SGRQ_ACTIVITY SGRQ_IMPACT
CAT cough 0.330a 0.124 0.197a
CAT phlegm 0.416a 0.207a 0.255a
CAT tightness 0.370a 0.282a 0.330a
CAT climbing stairs 0.422a 0.544a 0.525a
CAT household activities 0.372a 0.514a 0.496a
CAT security outside the house 0.392a 0.465a 0.540a
CAT sleeping 0.465a 0.435a 0.518a
CAT energy 0.391a 0.482a 0.501a
CAT: COPD Assessment Test; SGRQ: St. George Questionnaire.
aThe correlation is significant on level 0.01 (bilateral).
Table 4.Correlation coefficients of the questionnaires and
sample characteristics.
CAT score (R) SGRQ score (R)
Age 0.029 0.103
Level of studies 0.057 0.070
Dyspnea (MRC) 0.548a 0.419a
Cough 0.116 0.096
Expectoration 0.115 0.100
Wheezing 0.247a 0.270a
Daytime drowsiness 0.188a 0.234a
Fever 0.034 0.035
Edema 0.169b 0.197a
Need to sleep in sitting
position
0.249a 0.156b
Pain (VAS) 0.261 0.248a
No. of comorbidities 0.071 0.071
Charlson index 0.063 0.006
Anxiety 0.450a 0.549a
Depression 0.456a 0.571a
Barthel’s index 0.450a 0.405a
MRC: Medical Research Council; VAS: visual analogue scale; CAT:
COPD Assessment Test; SGRQ: St. George Questionnaire.
aThe correlation is significant on level 0.01(bilateral).
bThe correlation is significant on level 0.05 (bilateral).
Table 5. Multiple linear regression.
CAT score SGRQ score
Independent variables Ba pb Ba pb
Dyspnea (MRC) 3.155 0.000 2.625 0.073
Wheezing 1.504 0.108 5.068 0.022
Daytime drowsiness 0.585 0.602 1.541 0.561
Edema 1.054 0.305 0.376 0.884
Need to sleep in sitting
position
1.193 0.274 0.603 0.014
Anxiety 0.053 0.039 1.305 0.001
Depression 0.335 0.048 1.352 0.001
Barthel’s index 0.264 0.113 0.147 0.016
Summary of the model (R2) 0.394 0.435
MRC: Medical Research Council; CAT: COPD Assessment Test;
SGRQ: St. George Questionnaire.
aRegression coefficient.
bStatistical significance for Wald’s Chi squared.
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differences (p < 0.01) between the hospitals (Table 1).
There was a significant correlation (r ¼ 0.614;
p < 0.01) between the total scores of the CAT and
SGRQ questionnaires, as seen in the dispersion dia-
gram and Table 2. This strong correlation (p < 0.01)
was also noted between all of the questions from the
CAT questionnaire and the subscales (symptoms,
activity, impact) of the SGRQ questionnaire, except
for the presence of a cough in the CAT questionnaire
with the activity subscale of the SGRQ (r ¼ 0.124,
p > 0.05; Table 3).
The correlation between population
characteristics and total SGRQ and CAT scores
Regarding the internal consistency and reliability of
the scales, both had Cronbach’s a coefficients above
0.8 (CAT 0.827 vs. SGRQ 0.836; Table 2).
With respect to the relationship between the total
scores of the CAT and SGRQ with sample character-
istics, Pearson’s correlation coefficients showed a sig-
nificant correlation (p < 0.01) between both
questionnaires with the presence of dyspnea (CAT
r ¼ 0.548, p < 0.01 vs. SGRQ r ¼ 0.419, p < 0.01),
wheezing (CAT r ¼ 0.247, p < 0.01 vs. SGRQ r ¼
0.270, p < 0.01), daytime drowsiness (CAT r¼ 0.188,
p < 0.01 vs. SGRQ r¼ 0.270, p < 0.01), anxiety (CAT
r ¼ 0.450, p < 0.01 vs. SGRQ r ¼ 0.549, p < 0.01),
depression (CAT r ¼ 0.456, p < 0.01 vs. SGRQ r ¼
0.571, p < 0.01), and increased dependence on others
in the performance of activities of daily life (CAT r¼
0.450, p < 0.01 vs. SGRQ r ¼ 0.405, p < 0.01). Other
variables, such as the presence of edema, had greater
correlation with the SGRQ (r ¼ 419, p < 0.01) than
the CAT (r ¼ 0.197, p < 0.05). The need to sleep in a
sitting position had inverse results with the CAT (r ¼
0.249, p < 0.01) vs. the SGRQ (r ¼ 0.156, p < 0.05).
However, pain was significantly correlated only with
the SGRQ score (r ¼ 0.248, p < 0.01; Table 4).
To best determine which questionnaire can best
predict changes in variables related to HRQL, a mul-
tiple linear regression analysis was performed, intro-
ducing into the regression model those variables that
had a significant correlation p<0.01 with both ques-
tionnaires (dyspnea, wheezing, daytime drowsiness,
anxiety, depression, and dependence in performing
daily life activities). Three variables were obtained
from the CAT questionnaire that could predict HRQL,
with dyspnea, anxiety, and depression explaining
39.4% of the variance. The SGRQ had five variables
that could predict HRQL, with the wheezing, the need
to sleep in a sitting position, anxiety, depression, and
dependence in the execution of activities of daily liv-
ing able to explain 43.5% of the variance (Table 5).
Discussion
Based on our results, both questionnaires are similar
based on their psychometric properties. The SGRQ is
more precise than the CAT in the measurement of
HRQL in exacerbated patients in the hospital settings.
However, both questionnaires have high levels of
consistency for use in this type of population.
The sociodemographic profile of the sample was
similar in both centers and similar to data presented in
epidemiological work in Spain34 or internationally.35
Differences close to significance existed in aspects
such as educational level, where one of the centers
had a greater number of patients with university
degrees, which could justify the lower HRQL of
patients from the HUGC.36,37
Despite the homogeneity of the inclusion criteria of
both centers, patients had a higher degree of dyspnea,
expectoration, wheezing, daytime drowsiness, fever,
edema, the need to sleep in a sitting position, the pain,
number of comorbidities, anxiety, depression, and
dependence in the performance of daily activities in
the HUGC versus the HCB.
Both HRQL evaluation scales identified great
affectation of HRQL in COPD patients, results evi-
denced through three questionnaires in the Wacker
study.22 Our data are therefore in line with studies
that state that hospital admission and its duration are
associated with a reduced quality of life in patients
with COPD and greatly impact the patient’s
HRQL.38,39 Nonetheless, the degree of this impact
varied based on the questionnaire used and the center,
regardless of the initial clinical differences. The CAT
questionnaire scores were higher in the hospital
whose patients had the worst health statuses.
Both the SGRQ and CAT questionnaires have a
degree of internal consistency above 0.7, which is
similar to the review published by Weldam (9) on the
attributes of the questionnaires designed for HRQL
assessment in patients with respiratory problems, or
with other studies that have measured this item in
patients with stable COPD.21 SGRQ had the highest
levels of internal consistency in unstable COPD pop-
ulation COPD with requirement of hospital admis-
sion; these results were also identified in patients
with stable COPD.21
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A correlation between the results of both question-
naires has been previously evaluated, with values that
range from 0.72 to 0.84,8,11,15 which have even
achieved a correlation between the SGRQ subscales
with the total results of the CAT.25 However, the
study by Morishita-Katsu (21) with an outpatient pop-
ulation calculated a correlation of 0.668.
All the variables that were statistically significant
in the CAT questionnaire were significant in the
SGRQ, indicating that HRQL was related to vari-
ables, such as dyspnea,37,40–43 depression, 43–45 and
degree of immobility46,47 with a high level of signifi-
cance and support from prior scientific literature.
However, age was identified only by the SGRQ as a
predictor of changes in HRQL, and the results are
supported by prior scientific evidence.36,37,43,48 Pain
had a statistical relationship only with the SGRQ
scale, and it was associated with a worse perception
of HRQL and higher levels of perceived health.43 This
observation could be explained by the existence of an
item that evaluates pain in the SGRQ questionnaire,
which was not present in the CAT questionnaire.
In contrast, other variables such as age36,39,48–50
and the number and type of comorbidities24,51 were
not related to HRQL, standing against other studies
that do establish a relationship between them.
The multiple regression analysis revealed that only
39.4% of the variance of the CAT scores were
explained by dyspnea, anxiety, and depression, results
that would indicate the existence of other unmeasured
factors that would explain the CAT scores, like lung
function.47,49 The SGRQ revealed a greater explana-
tion of variance, with 43.5% explained by a higher
number of variables, including wheezing, the need to
sleep in sitting position, anxiety, depression, and
dependence. A similar result occurs in a population
with stable COPD, where the SGRQ can better predict
HRQL (63%) compared with the CAT (37%).21
Our results therefore support prior research that
concludes that the most suitable questionnaires for
assessing HRQL in patients with COPD are those
created specifically for patients with respiratory
pathology, given that they are not sensitive enough
to detecting changes in patient’s health status.51
This study is part of a broader evaluation of a struc-
tured therapeutic education program, whose principal
objective is not to compare both HRQL measurement
scales. Due to this, the time needed to complete the
questionnaire has not been evaluated and a test–retest
has not been performed on the same population to con-
firm the temporal stability of both questionnaires. Our
data collection method, which consists of a self-
administered modality vs. interview modality, has not
been considered. While both questionnaires are reliable
in both modalities, these have not been analyzed in
patients with exacerbated COPD in the hospital settings.
Conclusion
In conclusion, the CAT questionnaire has psycho-
metric properties similar to those of the SGRQ ques-
tionnaire, their internal consistency is similar, and there
is a strong correlation between both metrics. Hence, the
CAT questionnaire is a good assessment tool for
HRQL in exacerbated patients with COPD in the hos-
pital settings, when time is limited. Although the ques-
tionnaires are similar, in our regression analysis, the
SGRQ questionnaire was better able to predict changes
in HRQL with a higher number of variables. The CAT
questionnaire may differ from the SGRQ in the mea-
surement of HRQL because of the multiple circum-
stances that alter HRQL in exacerbated patients in
the hospital settings. Measurement may therefore be
more precise with the SGRQ questionnaire.
Declaration of conflicting interests
The author(s) declared no potential conflict of interest with
respect to the research, authorship, and/or publication of
this article.
Funding
The author(s) disclosed receipt of the following financial
support for the research, authorship, and/or publication of
this article: The study was partially funded by the Spanish
Society of Pneumology and Thoracic Surgery (SEPAR),
Nursing area (191/2013).
ORCID iD
Ana Folch Ayora http://orcid.org/0000-0002-0210-6162
Marı´a Isabel Orts-Corte´s http://orcid.org/0000-0002-
1504-575X
References
1. Godtfredsen NS, Lam TH, Hansel TT, et al.
COPD-related morbidity and mortality after smoking
cessation: status of the evidence. Eur Respir J 2008;
32(4): 844–853.
2. Mathers CD, Fat DM, Inoue M, et al. Counting the
dead and what they died from: an assessment of the
global status of cause of death data. Bull World Health
Organ 2005; 83(3): 171–177.
3. Miravitlles M, Soler-Catalun˜a J, Calle M, et al. Guı´a
espan˜ola de la enfermedad pulmonar obstructiva
8 Chronic Respiratory Disease 0(0)
cro´nica (GesEPOC) 2017. Tratamiento farmacolo´gico
en fase estable. Arch Bronconeumol 2017; 53(6):
324–335. Doi: 10.1016/j.arbres.2017.03.018.
4. Vestbo J, Hurd SS, Agustı´ AG, et al. Global strategy for
the diagnosis, management, and prevention of chronic
obstructive pulmonary disease: GOLD executive sum-
mary.AmJRespirCritCareMed2013; 187(4): 347–365.
5. Sullivan SD and Ramsey SC. The economic burden in
COPD. Chest 2000; 117: S5–S9.
6. Sedeno MF, Nault D, Hamd DH, et al. A self-
management education program including an action
plan for acute COPD exacerbations. COPD 2009;
6(5): 352–358.
7. Soler JJ, Martı´nez-Garcı´a MA, Roma´n P, et al. Effec-
tiveness of a specific program for patients with chronic
obstructive pulmonary disease and frequent exacerba-
tions. Arch Bronconeumol 2006; 42(10): 501–508.
8. Jones PW, Harding G, Berry P, et al. Development and
first validation of the COPD Assessment Test. Eur
Respir J 2009; 34(3): 648–654.
9. Weldam SWM, Schuurmans MJ, Liu R, et al. Evalua-
tion of quality of life instruments for use in COPD care
and research: a systematic review. Int J Nurs Stud
2013; 50(5): 688–707.
10. Ferrer M, Alonso J, Prieto L, et al. Validity and relia-
bility of the St George’s Respiratory Questionnaire
after adaptation to a different language and culture: the
Spanish example. Eur Respir J 1996; 9(6): 1160–1166.
11. Jones PW, Brusselle G, Dal Negro RW, et al. Proper-
ties of the COPD assessment test in a cross-sectional
European study. Eur Respir J 2011; 38(1): 29–35.
12. Agusti A, Soler-Catalun˜a JJ, Molina J, et al. Does the
COPD assessment test (CATTM) questionnaire pro-
duce similar results when self- or interviewer adminis-
tered? Qual Life Res 2015; 24(10): 2345–2354.
13. Jones PW. Quality of life measurement for patients
with diseases of the airways. Thorax 1991; 46:
676–682.
14. Jones PW, Quirk FH, Baveystock CM, et al. A
self-complete measure of health status for chronic air-
flow limitation: the St. George’s respiratory question-
naire. Am Rev Respir Dis 1992; 145(6): 1321–1327.
15. Ringbaek T, Martinez G, and Lange P. A comparison
of the assessment of quality of life with CAT, CCQ,
and SGRQ in COPD patients participating in pulmon-
ary rehabilitation. COPD J Chronic Obstr Pulm Dis
2012; 9(1): 12–15.
16. Harper R, Brazier JE, Waterhouse JC, et al. Compar-
ison of outcome measures for patients with chronic
obstructive pulmonary disease (COPD) in an outpati-
ent setting. Thorax 1997; 52(10): 879–887.
17. Tsiligianni IG, Alma HJ, de Jong C, et al. Investigating
sensitivity, specificity, and area under the curve of the
Clinical COPD Questionnaire, COPD Assessment
Test, and Modified Medical Research Council scale
according to GOLD using St George’s Respiratory
Questionnaire cutoff 25 (and 20) as reference. Int J
Chron Obstruct Pulmon Dis 2016; 11: 1045–1052.
18. Ninot G, Soyez F, and Pre´faut C. A short questionnaire
for the assessment of quality of life in patients with
chronic obstructive pulmonary disease: psychometric
properties of VQ11. Health Qual Life Outcomes 2013;
11: 179.
19. Chaplin E, Gibb M, Sewell L, et al. Response of the
COPD assessment tool in stable and postexacerbation
pulmonary rehabilitation populations. J Cardiopulm
Rehabil Prev 2015; 35(3): 214–218.
20. Hajiro T, Nishimura K, Tsukino M, et al. Comparison of
discriminative properties among disease-specific ques-
tionnaires for measuring health-related quality of life in
patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 1998; 157(4): 785–790.
21. Morishita-Katsu M, Nishimura K, Taniguchi H, et al. The
COPD assessment test and St George’s Respiratory Ques-
tionnaire: are they equivalent in subjects with COPD? Int
J Chron Obstruct Pulmon Dis 2016; 11: 1543–1551.
22. Huber MB, Wacker ME, Vogelmeier CF, et al. Comor-
bid influences on generic health-related quality of life
in COPD: a systematic review. PLoS One 2015; 10(7):
e0132670.
23. Jones PW, Tabberer M, and Chen WH. Creating sce-
narios of the impact of COPD and their relationship to
COPD Assessment Test (CATTM) scores. BMC Pulm
Med 2011; 11: 42.
24. Smid DE, Wilke S, Jones PW, et al. Impact of cardiovas-
cular comorbidities on COPD Assessment Test (CAT)
and its responsiveness to pulmonary rehabilitation in
patients with moderate to very severe COPD: protocol
of the Chance study. BMJ Open 2015; 5(7): e007536.
25. Nagata K, Tomii K, Otsuka K, et al. Evaluation of the
chronic obstructive pulmonary disease assessment test for
measurement of health-related quality of life in patients
with interstitial lung disease. Respirology 2012; 17(3):
506–512. DOI: 10.1111/j.1440-1843.2012.02131.x
26. Hernandez Carcereny C, Seijas N, Folch A, et al.
Impact of therapeutic education program for COPD
patients on preventing readmissions (Aprendeepoc).
In: 93 Nurses. Eur Respir Soc 2016; PA1614.
27. Folch A, Orts-Corte´s MI, Herna´ndez-Carcereny C, et
al. Programas educativos en pacientes con Enfermedad
Pulmonar Obstructiva Cro´nica. Revisio´n integradora.
Enfermerı´a Glob 2016; 16(1): 537.
Folch Ayora et al. 9
28. Alonso-Ferrer J, Mon-Plaza L, and Prieto V. St George
validity and reliability of the Spanish version of the St.
George’s Respiratory Questionnaire.
29. Casanova Macarioa C, Garcı´a-Talavera Martı´n I, and
de Torres Taje´s JP. La disnea en la EPOC. Arch
Bronconeumol 2005; 41(Supl 3): 24–32.
30. Wang R and Ma X. Clarification on the categorization
of comorbidities. Leuk Res 2010; 34(2): e74.
31. Tejero A, Guimera´ E, Farre´ J, et al. Uso clı´nico del
HAD (Hospital Anxiety and Depression Scale) en
poblacio´n psiquia´trica: Un estudio de su sensibilidad;
fiabilidad y validez. Rev del Dep Psiquiatr la Fac Med
Barcelona 2015; 13: 233–238.
32. Vallejo MA, Rivera J, Esteve-Vives J, et al. Use of the
Hospital Anxiety and Depression Scale (HADS) to
evaluate anxiety and depression in fibromyalgia
patients. Rev Psiquiatr y salud Ment 2012; 5(2):
107–114.
33. Cid-Ruzafa J and Damia´n-Moreno J. Valoracio´n de la
discapacidad fı´sica: el indice de Barthel. Rev Esp Salud
Publica 1997; 71(2): 127–137.
34. Soriano JBM. Datos epidemiolo´gicos de EPOC en
Espan˜a. Arch Bronconeumol 2007; 43(Supl 1): 2–9.
35. Siddique HH, Olson RH, Parenti CM, et al. Rando-
mized trial of pragmatic education for low-risk COPD
patients: impact on hospitalizations and emergency
department visits. Int J Chron Obstruct Pulmon Dis
2012; 7: 719–728.
36. Mroczek B, Sitko Z, Augustyniuk K, et al. Socioeco-
nomic Indicators Shaping Quality of Life and Illness
Acceptance in Patients with Chronic Obstructive Pul-
monary Disease. In: Pokorski M. (eds) Respiratory
Health. Advances in Experimental Medicine and Biol-
ogy, vol 861. Springer International Publishing, 2015,
p. 19–30.
37. Hong Y, Lim MN, Kim WJ, et al. Influence of envi-
ronmental exposures on patients with chronic obstruc-
tive pulmonary disease in Korea. Tuberc Respir Dis
(Seoul) 2014; 76(5): 226–232.
38. Sahadevan A, Baily C, Cullen L, et al. The efficacy of
COPD outreach in reducing length of stay and improv-
ing quality of life. Ir Med J 2015; 108(6): 169–171.
39. Hong JY, Kim SY, Chung KS, et al. Factors associated
with the quality of life of Korean COPD patients as
measured by the EQ-5D. Qual Life Res 2015; 24(10):
2549–2558.
40. Barusso MS, Gianjoppe-Santos J, Basso-Vanelli RP, et
al. Limitation of activities of daily living and quality of
life based on COPD combined classification. Respir
Care 2015; 60(3): 388–398.
41. Siebeling L, Musoro JZ, Geskus RB, et al. Prediction
of COPD-specific health-related quality of life in pri-
mary care COPD patients: a prospective cohort study.
NPJ Prim care Respir Med 2014; 24: 14060.
42. Weldam SWM, Lammers JWJ, Heijmans MJWM, et
al. Perceived quality of life in chronic obstructive pul-
monary disease patients: a cross-sectional study in pri-
mary care on the role of illness perceptions. BMC Fam
Pract 2014; 15: 140.
43. Villar Balboa I, Carrillo Mun˜oz R, Regı´ Bosque M, et
al. Factores relacionados con la calidad de vida de los
pacientes con enfermedad pulmonar obstructiva cro´-
nica. Atencio´n Primaria 2014; 46(4): 179–187.
44. Sundh J, Johansson G, Larsson K, et al. Comorbidity
and health-related quality of life in patients with severe
chronic obstructive pulmonary disease attending
Swedish secondary care units. Int J Chron Obstruct
Pulmon Dis 2015; 10: 173–183.
45. Ioanna T, Kocks J, Tzanakis N, et al. Factors that
influence disease-specific quality of life or health sta-
tus in patients with COPD: a systematic review and
meta-analysis of Pearson correlations. Prim Care
Respir J 2011; 20(3): 257–268.
46. Caulfield B, Kaljo I, and Donnelly S. Use of a con-
sumer market activity monitoring and feedback device
improves exercise capacity and activity levels in
COPD. In: 2014 36th Annual International Conference
of the IEEE Engineering in Medicine and Biology
Society. 26-30 August 2014, p. 1765–1768. Chicago:
IEEE.
47. Nonato NL, Dı´az O, Nascimento OA, et al. Compor-
tamiento de la calidad de vida (SGRQ) en pacientes
con EPOC segu´n las puntuaciones BODE. Arch Bron-
coneumol 2015; 51(7): 315–321.
48. Wu M, Zhao Q, Chen Y, et al. Quality of life and its
association with direct medical costs for COPD in
urban China. Health Qual Life Outcomes 2015; 13: 57.
49. Nagai K, Makita H, Suzuki M, et al. Differential
changes in quality of life components over 5 years in
chronic obstructive pulmonary disease patients. Int J
Chron Obstruct Pulmon Dis 2015; 10: 745–757.
50. Holm KE, Plaufcan MR, Ford DW, et al. The impact of
age on outcomes in chronic obstructive pulmonary dis-
ease differs by relationship status. J Behav Med 2014;
37(4): 654–663.
51. Wacker ME, Jo¨rres RA, Karch A, et al. Assessing
health-related quality of life in COPD: comparing
generic and disease-specific instruments with
focus on comorbidities. BMC Pulm Med 2016;
16(1): 70.
10 Chronic Respiratory Disease 0(0)
